OLEMA PHARMACEUTICALS INC's ticker is OLMA and the CUSIP is 68062P106. A total of 76 filers reported holding OLEMA PHARMACEUTICALS INC in Q2 2022. The put-call ratio across all filers is 0.44 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,160,097 | +247.4% | 93,935 | +154.0% | 0.00% | – |
| Q2 2023 | $333,974 | +135.3% | 36,985 | -9.6% | 0.00% | – |
| Q1 2023 | $141,906 | +81.0% | 40,895 | +27.8% | 0.00% | – |
| Q4 2022 | $78,383 | -85.0% | 31,993 | -83.1% | 0.00% | – |
| Q3 2022 | $522,000 | -37.5% | 189,009 | -7.9% | 0.00% | – |
| Q2 2022 | $835,000 | -56.0% | 205,297 | -54.0% | 0.00% | – |
| Q1 2022 | $1,899,000 | -6.7% | 445,948 | +104.9% | 0.00% | – |
| Q4 2021 | $2,036,000 | -51.0% | 217,600 | +44.5% | 0.00% | -100.0% |
| Q3 2021 | $4,151,000 | +202.1% | 150,619 | +206.7% | 0.00% | – |
| Q2 2021 | $1,374,000 | +96.3% | 49,112 | +132.7% | 0.00% | – |
| Q1 2021 | $700,000 | -73.6% | 21,101 | -61.7% | 0.00% | -100.0% |
| Q4 2020 | $2,652,000 | – | 55,165 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Logos Global Management LP | 3,743,875 | $180,006,000 | 15.43% |
| BVF INC/IL | 6,661,503 | $320,285,000 | 12.60% |
| VR Adviser, LLC | 1,536,193 | $73,860,000 | 10.86% |
| Foresite Capital Management IV, LLC | 818,030 | $39,331,000 | 4.27% |
| Cormorant Asset Management, LP | 3,195,544 | $148,169,000 | 3.53% |
| Vivo Capital, LLC | 1,238,575 | $59,551,000 | 2.66% |
| RA Capital Management | 2,150,404 | $103,391,000 | 1.44% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 696,191 | $33,473,000 | 0.66% |
| Avoro Capital Advisors LLC | 876,986 | $35,646,000 | 0.61% |
| Avidity Partners Management LP | 270,000 | $12,982,000 | 0.42% |